These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 1398519)

  • 1. Diagnostic difficulties in 'non-mycotic' cutaneous lymphoproliferative diseases.
    Slater DN
    Histopathology; 1992 Sep; 21(3):203-13. PubMed ID: 1398519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approach to lymphoproliferative infiltrates of the skin. The difficult lesions.
    Kempf W; Dummer R; Burg G
    Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S84-93. PubMed ID: 9894473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous pseudolymphomas: classification and differential diagnosis.
    Rijlaarsdam JU; Willemze R
    Semin Dermatol; 1994 Sep; 13(3):187-96. PubMed ID: 7986687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic reassessment of non-mycosis fungoides primary cutaneous lymphomas during 17 years.
    Bergman R; Marcus-Farber BS; Manov L; Nerodinisky I; Epelbaum R; Sahar D; Schein-Goldschmid R; Ramon M; Ben-Arieh Y
    Int J Dermatol; 2002 Nov; 41(11):735-43. PubMed ID: 12452994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinico-pathological spectrum of primary cutaneous lymphoma other than mycosis fungoides/Sezary syndrome.
    Oschlies I; King RL; Dotlic S; Montes-Moreno S; Ponzoni M; Traverse-Glehen A; Calaminici M; Ferry JA; Ott G; Goodlad JR
    Virchows Arch; 2020 May; 476(5):683-699. PubMed ID: 31781845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone.
    Davis TH; Morton CC; Miller-Cassman R; Balk SP; Kadin ME
    N Engl J Med; 1992 Apr; 326(17):1115-22. PubMed ID: 1532439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
    Slater DN
    Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
    Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
    Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous T-cell lymphoproliferative disorders: approach for the surgical pathologist: recent advances and clarification of confused issues.
    Liu V; McKee PH
    Adv Anat Pathol; 2002 Mar; 9(2):79-100. PubMed ID: 11917163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cutaneous lymphomas: new entities and rare variants].
    Kempf W; Mitteldorf C
    Pathologe; 2015 Feb; 36(1):62-9. PubMed ID: 25589355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases.
    Kikuchi A; Nishikawa T
    Arch Dermatol; 1997 Jul; 133(7):829-33. PubMed ID: 9236520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
    Paulli M; Berti E
    Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of cutaneous lymphomas in Osaka, Japan (1988-1999) based on the European Organization for Research and Treatment of Cancer classification.
    Nagasawa T; Miwa H; Nakatsuka S; Itami S; Yoshikawa K; Aozasa K
    Am J Dermatopathol; 2000 Dec; 22(6):510-4. PubMed ID: 11190442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation, Diagnosis, and Staging of Cutaneous Lymphoma.
    Olsen EA
    Dermatol Clin; 2015 Oct; 33(4):643-54. PubMed ID: 26433839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphoma of the skin.
    Connors JM; Hsi ED; Foss FM
    Hematology Am Soc Hematol Educ Program; 2002; ():263-82. PubMed ID: 12446427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [WHO classification and clinical spectrum of cutaneous lymphomas].
    Mitteldorf C; Grabbe S; Stadler R
    Hautarzt; 2017 Sep; 68(9):682-695. PubMed ID: 28831508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spectrum of cutaneous lymphomas in patients less than 20 years of age.
    Fink-Puches R; Chott A; Ardigó M; Simonitsch I; Ferrara G; Kerl H; Cerroni L
    Pediatr Dermatol; 2004; 21(5):525-33. PubMed ID: 15461755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment.
    Willemze R; Beljaards RC
    J Am Acad Dermatol; 1993 Jun; 28(6):973-80. PubMed ID: 8388410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of cutaneous lymphomas in Japan: a study of 62 cases based on the World Health Organization Classification.
    Yasukawa K; Kato N; Kodama K; Hamasaka A; Hata H
    J Cutan Pathol; 2006 Jul; 33(7):487-91. PubMed ID: 16872471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoproliferative lesions of the skin.
    Cerroni L
    J Clin Pathol; 2006 Aug; 59(8):813-26. PubMed ID: 16873563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.